Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 5/2011

01-05-2011 | Letter

Finnish Current Care Guideline for Diabetes: interactive approach to improve individualised treatment

Authors: A. Virkamäki, J. Saltevo

Published in: Diabetologia | Issue 5/2011

Login to get access

Excerpt

Dr R. Kahn recently wrote a Commentary in Diabetologia regarding the need to improve clinical guidelines [1]. We would like to highlight some practical and readily available ways of overcoming many of the problems raised by Kahn in his excellent paper. …
Literature
1.
Kahn R (2010) Guidelines: we’ll always need them, we sometimes dislike them, and we have to make them better. Diabetologia 53:2280–2284PubMedCrossRef
2.
Diabetes Current Care Guideline. Working group set up by the Finnish Medical Society Duodecim and the Finnish Society of Internal Medicine. Helsinki: Finnish Medical Society Duodecim, 2009. Available from: www.​kaypahoito.​fi. Accessed 3 Nov 2010 (in Finnish)
3.
4.
The Action to Control Cardiovascular Risk in Diabetes Study Group (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545–2559CrossRef
5.
Duckworth W, Abraira C, Moritz T et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129–139PubMedCrossRef
6.
The ADVANCE Collaborative Group (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572CrossRef
7.
Metadata
Title
Finnish Current Care Guideline for Diabetes: interactive approach to improve individualised treatment
Authors
A. Virkamäki
J. Saltevo
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2056-1

Other articles of this Issue 5/2011

Diabetologia 5/2011 Go to the issue

Article

Founder effect in the Horn of Africa for an insulin receptor mutation that may impair receptor recycling

Article

Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies

Article

The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes

Erratum

Erratum to: Type 2 diabetes risk allele near CENTD2 is associated with decreased glucose-stimulated insulin release

Article

Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide

Article

Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits